Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy · 11.01.2025 · 10 (8) · 652-661
DOI: 10.1093/ehjcvp/pvae066 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, online erschienen am 30.10.2024. Verfasst von Nadia Salerno und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Magna Graecia University, Viale Europa, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Atrial Fibrillation, Recurrence. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Ministry of University and Research, National Center for Gene Therapy and Drugs based, Italian Ministry of Health.
Abstract (Originalsprache)
Background
The overall risk of long-term adverse events of a transient episode of new-onset atrial fibrillation (AF) in patients with acute coronary syndrome (ACS) remains uncertain. This meta-analysis aimed to assess the prognostic impact of transient new-onset AF complicating ACS. Methods and results Cohort studies examining the risk of adverse events in patients with transient new-onset AF compared to those in sinus rhythm after ACS were identified through a comprehensive search of MEDLINE, Scopus, Cochrane, and Google Scholar Library. Studies reporting the incidence of ischaemic stroke events, recurrent AF, or all-cause mortality at the longest follow-up were included. Adjusted hazard ratios (aHRs) with 95% confidence intervals (CI) were synthesized using inverse variance-weighted random-effects meta-analysis. In the seven observational studies included, comprising 151 735 patients, 6 597 (4.3%) experienced transient new-onset AF, which was associated with an increased risk of ischaemic stroke, recurrent AF, or all-cause mortality (HR: 2.24, 95% CI: 1.75–2.85; P < 0.0001; I2 = 30.76%; seven studies). The results remained consistent across each individual endpoint, including ischaemic stroke (HR 2.38, 95% CI: 1.64–3.44; P < 0.01; I2 = 50.2%; five studies), recurrent AF (HR 4.68, 95% CI: 2.07–10.59; P = 0.0002; I2 = 50.2%; four studies), and all-cause mortality (HR 1.36, 95% CI: 1.08–1.71; P = 0.0089; I2 = 53.25%; four studies). Meta-regression analyses revealed a significant increase in these adverse events associated with ST-elevation myocardial infarction (P = 0.001), while there was a tendency for their decrease associated with oral anticoagulant prescription at discharge (P = 0.07).
Conclusions
The occurrence of transient new-onset AF is associated with an elevated long-term risk of stroke, recurrent AF, and all-cause mortality in patients with ACS. Consequently, these data urge randomized clinical trials to assess the best antithrombotic regimen while potentially helping the current treatment decision-making process for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, Magna Graecia University, Viale Europa, 88100 Catanzaro, Italy.
- Department of Medical and Surgical Sciences, Magna Graecia University, Viale Europa, 88100 Catanzaro, Italy.
ORCID-Profile: Nadia Salerno, Jolanda Sabatino, Salvatore De Rosa, Daniele Torella
Förderung
- Italian Ministry of University and Research
- National Center for Gene Therapy and Drugs based
- Italian Ministry of Health
Zitieren
APA
Salerno, N., Ielapi, J., Cersosimo, A., Leo, I., Sabatino, J., De Rosa, S., Sorrentino, S., & Torella, D. (2025). Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy, 10(8), 652-661. https://doi.org/10.1093/ehjcvp/pvae066
Vancouver
Salerno N, Ielapi J, Cersosimo A, Leo I, Sabatino J, De Rosa S, et al. Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 2025;10(8):652-661. doi:10.1093/ehjcvp/pvae066
BibTeX
@article{Salerno2025,
author = {Salerno, Nadia and Ielapi, Jessica and Cersosimo, Angelica and Leo, Isabella and Sabatino, Jolanda and De Rosa, Salvatore and Sorrentino, Sabato and Torella, Daniele},
title = {Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2025},
volume = {10},
number = {8},
pages = {652--661},
doi = {10.1093/ehjcvp/pvae066}
}
EUVIMED